Therapy with metformin, DPP-4 inhibitors, SGLT2 inhibitors, arGLP-1 before the infection and anti-COVID-19 vaccination were associated with a lower CFR, while SU and insulin therapy was associated with a higher CFR due to COVID-19. This evidence concerns the gene SLC5A2 and COVID-19.